Santosh received his B.Sc. in Biological sciences from DDU, India in 2002, followed by M.Sc. in organic chemistry from LU, India in 2005. He did phytochemical evaluation work for anti-baldness phyto-medicine at National Botanical Research Institute, India in 2006. He was awarded with CSIR-NET in 2006 and 2007. He gained his doctorate from the Dept. of Organic Chemistry at Indian Institute of Science in 2013. His research work was submitted as thesis entitled “Synthesis and Characterization of Cationic Lipids and Carbon Nanomaterials Based Composites for the Delivery of Bioactive Oligo/polynucleotides and Drugs in vitro and in vivo”. He achieved his Ph.D. under guidance of Prof. Santanu Bhattacharya (Professor at Dept. of Organic Chemistry, Indian Institute of Science and Chemical Biology Unit of JNCASR, India). He has been awarded with prestigious “The Guha Research Medal” for his Ph.D. research work. During his Ph.D., he worked with Prof. Paturu Kondaiah (Cancer Biologist) of MRDG department at Indian Institute of Science, India and Prof. Emilio Aicart (Bio-physical Chemist) of Dpto. Quimica Fisica, Facultad C. Quimicas, Madrid, Spain. He also worked in collaboration with Prof. C. N. R. Rao (Material Chemist; Bharat Ratna) of JNCASR, Bangalore, India, Prof. Wei Duan (Medical biologist) of School of Medicine, Deakin University, Australia and Prof. Pascal Dumy (Peptide chemist) of DCM, Grenoble, France.
Dr. Santosh Misra, has been working in field of biomedical materials from around a decade and have specific training for synthesis of molecules of biological importance, their physico-chemical characterization, in vitro and in vivo biological studies and clinical trials. He joined the group of Prof. Dipanjan Pan, in October, 2013. His major research interests are engineering clinically translatable nano-assemblies for biomedical applications by using organic and biomaterial synthesis and nanotechnology and using them under molecular biology, biology, gene and drug delivery, bio-engineering, bio- and molecular imaging and pro-drug strategies to understand chemistry, biology, physiology and engineering of novel solutions to various diseases. His primary approach has been to target newly discovered protein/gene players in cancer cascade and establish nanomedicine approach to modulate their functioning. His recent research avenues include synthesizing physiologically controllable pro-drugs, preparation of nano-assemblies and co-nano-assemblies using biocompatible materials ranging from lipids, polypeptides and polynucleotide derivatives with or without targeting virtues for local or systemic usages. He is working on some of the novel biomaterial composites for 3D printing biomedical devices for personalized medicinal use. On the other side of the nanomaterial spectrum, he is also working on materials of environmental sustainability importance, bio-and agro-sensors and skin patches. As a junior and senior research fellow, project associate and postdoctoral researcher at different time points of his career, he has been handling projects of high international collaborations and great importance to biomedical science fraternity.”